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Nanotechnology versus stem cell engineering: 
in vitro comparison of neurite inductive potentials
Purpose: Innovative nerve conduits for peripheral nerve reconstruction are needed in order to 
specifically support peripheral nerve regeneration (PNR) whenever nerve autotransplantation is 
not an option. Specific support of PNR could be achieved by neurotrophic factor delivery within 
the nerve conduits via nanotechnology or stem cell engineering and transplantation.
Methods: Here, we comparatively investigated the bioactivity of selected neurotrophic fac-
tors conjugated to iron oxide nanoparticles (np-NTFs) and of bone marrow-derived stem cells 
genetically engineered to overexpress those neurotrophic factors (NTF-BMSCs). The neurite 
outgrowth inductive activity was monitored in culture systems of adult and neonatal rat sensory 
dorsal root ganglion neurons as well as in the cell line from rat pheochromocytoma (PC-12) 
cell sympathetic culture model system.
Results: We demonstrate that np-NTFs reliably support numeric neurite outgrowth in all utilized 
culture models. In some aspects, especially with regard to their long-term bioactivity, np-NTFs 
are even superior to free NTFs. Engineered NTF-BMSCs proved to be less effective in induc-
tion of sensory neurite outgrowth but demonstrated an increased bioactivity in the PC-12 cell 
culture system. In contrast, primary nontransfected BMSCs were as effective as np-NTFs in 
sensory neurite induction and demonstrated an impairment of neuronal differentiation in the 
PC-12 cell system.
Conclusion: Our results evidence that nanotechnology as used in our setup is superior over 
stem cell engineering when it comes to in vitro models for PNR. Furthermore, np-NTFs can 
easily be suspended in regenerative hydrogel matrix and could be delivered that way to nerve 
conduits for future in vivo studies and medical application.
Keywords: iron oxide nanoparticles, conjugated neurotrophic factors, bone marrow-derived 
mesenchymal stem cells, genetic cell engineering, neurite outgrowth
Introduction
Tissue engineering of peripheral nerves is an active field in research and develop-
ment. Tissue-engineered nerves could become a valuable alternative to autologous 
nerve grafts, which are used as the gold standard for peripheral nerve reconstruction 
surgeries.1 This type of surgery is indicated whenever complete transection injuries 
of a peripheral nerve cannot be repaired by tension-free end-to-end coaptation of the 
severed nerve ends.2 Tissue engineering of peripheral nerves in order to bridge nerve 
defects and provide an optimized regenerative milieu is a complex effort that can 
only be achieved in a multidisciplinary setting.3 One important task is the delivery of 
regeneration-promoting molecules such as neurotrophic factors (NTFs) into the nerve 
defect or, more specifically, their application together with the artificial nerve graft. 
The main drawback in NTF application is the short half-life time, causing minimal 
efficacy of single NTF application at the time of reconstructive surgery or systemic 
application. Different ways to ensure extended availability of added NTFs at the site 
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of nerve reconstruction have been attempted in recent years, 
including gene therapy via transplanted Schwann cells4 or 
nanotechnology approaches.5
Ex vivo gene therapy can be used to genetically induce 
the overexpression of selected NTFs in cells that are later 
transplanted as part of tissue-engineered nerve grafts.6 The 
usefulness of this approach has been proven already for 
transplanted Schwann cells overexpressing different iso-
forms of fibroblast growth factor-2 (FGF-2) in the rat sciatic 
nerve model.7,8 Schwann cells are crucially involved in 
successful peripheral nerve regeneration (PNR), but they 
are not easy to harvest and propagate for cell transplanta-
tion strategies. Therefore, mesenchymal stem cells (MSCs) 
have been addressed as an easy to access and potentially 
unlimited cell source for tissue-engineered nerve grafts.9 In 
this study, we performed stem cell engineering by nonviral 
genetic modification of bone marrow-derived mesenchymal 
stem cells (BMSCs), resulting in overexpression of selected 
NTFs. Another option to ensure availability of NTFs within 
an artifical nerve graft is the conjugation of the proteins to 
nanoparticles and their delivery within a hydrogel matrix 
for axonal regeneration. This strategy was also evaluated 
in the current work as an alternative strategy to cell-based 
delivery of NTFs.
Three well-defined NTFs have been analyzed in the 
presented study. Nerve growth factor (NGF) is known as 
the neurotrophin with the strongest effect on sensory neu-
rite outgrowth with regard to both axonal elongation and 
sprouting.10 The second neurotrophin analyzed was glia-
derived neurotrophic factor (GDNF), which exerts the most 
prominent effects on regenerating motor neurons.11 The growth 
factor FGF-2, in particular its low molecular weight isoform 
FGF-218kDa, has demonstrated significant support on axonal 
elongation along with reduced sprouting.12 For the study pre-
sented, all three NTFs named were conjugated to iron oxide 
nanoparticles while overexpression of exclusively FGF-218kDa 
or GDNF was induced in BMSCs. Sensory neurite outgrowth 
assays as well as the cell line from rat pheochromocytoma 
cells (PC-12) neuronal differentiation assay were utilized to 
quantitatively analyze the regeneration-promoting potential 
of NTF-overexpressing BMSCs or nanoparticle-conjugated 
NTFs in comparison with free recombinant NTF proteins.
Materials and methods
synthesis of np-NTFs
Dextran-coated iron oxide magnetic nanoparticles of, on 
average, 10 nm dry diameters were prepared as described 
previously.13 The proteins βNGF, GDNF, and FGF-218kDa 
(PeproTech Asia, Rehovot, Israel) were covalently  conjugated 
to the dextran coating layer through the divinyl sulfone 
binding reagent, as described previously.5,14,15 Utilizing 
the appropriate enzyme-linked immunosorbent assay kits 
( PeproTech Asia, Rehovot, Israel, and Boster Immunoleader, 
Pleasanton, CA, USA), the concentration of each protein 
conjugated to the nanoparticles was determined. Stock aque-
ous nanoparticle suspensions, with a final concentration of 
10 ng/µL of each NTF (np-NTF), were used for the in vitro 
evaluations.
In vitro techniques
The harvest of material for tissue and cell culture was 
approved by the local animal protection committees in 
Torino, Piemonte, Italy, and Hannover, Lower-Saxony, 
Germany. Figure 1 summarizes details about the different 
culture systems used in this study.
adult dorsal root ganglion explant cultures
The spinal column of adult Hannover Wistar rats (approxi-
mately 250 g body weight, Harlan, Verona, Italy) was 
removed after euthanasia. To reach the spinal cord, the ver-
tebral bodies were cut off and removed. Using fine scissors, 
the vertebral canal was opened through a double cut on both 
sides of the vertebral bodies. On both sides of the spinal cord, 
dorsal root ganglia (DRGs) were reached along the poste-
rior roots and extracted from the intervertebral foramina. 
Harvested DRGs were maintained in Leibovitz’s medium 
(Invitrogen, Monza, Italy) for 1 hour under sterile condi-
tions. The connective tissue capsules were then mechanically 
reduced and the explants were half cut. The DRG explants 
were cultured on matrigel-coated (BD Biosciences, Bedford, 
MA, USA) glass coverslips in serum-free medium (SFM16): 
50% (v/v) F12 nutrient mixture, 50% (v/v) Basal Medium 
Eagle, 2×10-3 M glutamine, 0.5% (v/v) 100× penicillin–
streptomycin–neomycin antibiotic mixture (all Invitrogen), 
10 mg/mL bovine albumin serum, 1×10-4 M putrescine, 
0.1 mg/mL transferrin, 3×10-8 selenium, 0.005 mg/mL insu-
lin, 3.8×10-5 M vitamin C, 7.5 mg/mL glucose (all Sigma, 
Milan, Italy) in culture-grade water (Figure 1A).
To evaluate the stability of NTF bioactivity in vitro, free 
recombinant GDNF (Peprotech, Hamburg, Germany) and 
np-GDNF were selected, and adult DRG explant cultures 
were either incubated with fresh or preincubated pure SFM 
or supplemented with either GDNF type. Preincubated SFM 
formulations were prepared by incubating the medium for 
1 week or 2 weeks at 37°C and 5% CO
2
. Afterward, this 
medium was used for DRG explant cultures.
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A Adult rat DRG explants
B Dissociated neonatal DRG (P1–P3)
C PC-12 cells
Serum-free medium (SFM)
N2-medium
BMSC medium
50% F12 nutrient mixture
50% Basal Medium Eagle (BME)
2×10–3 M glutamine
0.5% 100× PSN antibiotic mixture
10 mg/mL BSA
Cell medium
with/without
factors
A drop with 2,500
neurons was seeded
inside the gel layer
30×104 EGFP-PC-12 cells
were mixed with the gel
0.5% NVR-Gel in cell medium
with/without factors
0.5% NVR-Gel in cell medium
with/without factors
Analysis of sensory
neurite outgrowth
Analysis of the length
of neuritic processes
0.5% NVR-Gel in cell medium with 40×104
BMSC cells that release factor
0.5% NVR-Gel in cell medium with 40×104
BMSC cells that release factor
Matrigel (dilution 1:2) coated glass-coverslip
Analysis of sensory
neurite outgrowth
3 days
1 day
5 days
0.1 mg/mL transferrin
3×10–8 M selenium
0.005 mg/mL insulin
3.8×10–5 M VitC
7.5 mg/mL glucose
DMEM F12
1% pen/strep
0.25% BSA
2 mM L-glutamine
1 mM sodium pyruvate
1× N2 supplement
Alpha-MEM medium
10% FCS
1% pen/strep
PC-12 differentiation medium
DMEM high glucose
1% FCS
1% horse serum
100 U/mL pen/strep
1 µM sodium pyruvate
4 µM L-glutamine
Figure 1 schematic illustration of culture models used in this study. 
Notes: (A) To evaluate the bioactivity (neurite outgrowth inductive potential) of np-NTFs, half-cut adult Drg explants were maintained for 3 days in sFM at 37°c with 5% 
cO2 and sister cultures were stimulated with three different quantities (10 ng/ml, 50 ng/ml, or 100 ng/ml) of each single np-NTF (np-NgF, np-FgF-2
18kDa, or np-gDNF) or 
with a pool of the three np-NTFs (final concentration of each np-NTF 30 ng/mL or 50 ng/mL). (B, upper row) Neonatal Drgs were dissociated and seeded as a drop (2,500 
neurons in 5 µl medium) into a layer of 800 or 1,000 µl of NVr-gel (pure or supplemented with either single free recombinant NTFs or np-NTFs or a pool of either the 
free NTFs or np-NTFs). (B, lower row) In addition, Drg drop cultures were seeded into NVr-gel containing nontransfected BMscs or BMscs overexpressing selected 
NTFs at a density of 40×104 cells/1,000 µl of 0.5% NVr-gel. cultures were maintained for 1 day. (C) a density of 30×104 egFP-Pc-12 cells was mixed with either np-NTFs 
or 40×104 nT-BMscs or FgF-218kDa-BMscs in a volume of 1 ml 0.5% NVr-gel (containing Pc-12 cell differentiation medium) and transferred into a 24-multiwell culture 
well. cultures were maintained for 5 days.
Abbreviations: np, nanoparticle; NTFs, neurotrophic factors; DRG, dorsal root ganglion; SFM, serum-free medium; NGF, nerve growth factor; FGF, fibroblast growth 
factor; GDNF, glia-derived neurotrophic factor; BMSCs, bone marrow-derived mesenchymal stromal cells; EGFP, enhanced green fluorescent protein; PC-12 cells, cell 
line from rat pheochromocytoma cells; PSN, penicillin–streptomycin–neomycin; BSA, bovine serum albumin; DMEM, Dulbecco’s Modified Eagle’s Medium; MEM, Minimum 
essential Medium; Fcs, fetal calf serum; pen/strep, penicillin/streptomycin.
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Preparation of NVr-gel for neurite 
outgrowth assays
NVR-Gel17 was used as a matrix for seeding drops of dissoci-
ated neonatal rat DRG (Figure 1B). NVR-Gel is composed 
of high molecular weight hyaluronic acid (3×106 Da, BTG 
Polymers, Kiryat Malachi, Israel) and laminin (Sigma, 
Rehovot, Israel). For cell cultivation, hyaluronic acid of 
1% was further diluted 1:1 either with N2 cell culture 
medium (see Figure 1B) or PC12 differentation medium 
(see Figure 1C) to a final concentration of 0.5%. Laminin was 
then added (10 ng/mL) to complete the NVR-Gel composi-
tion. For bioactivity assays, NVR-Gel was either left pure 
or enriched with 50 ng/mL of single free recombinant NTF 
(NGF, Invitrogen, Darmstadt, Germany; FGF-2 and GDNF, 
Peprotech, Hamburg Germany) or single np-NTFs or a pool 
of either the free NTFs or np-NTFs (50 ng/mL each). In the 
alternative setting, nontransfected BMSCs or BMSCs over-
expressing selected NTFs (see next section) were seeded into 
the NVR-Gel (Figure 1B).
harvest and culture of rat BMscs
Isolation and culturing of rat BMSCs from the femur bone 
marrow of adult Hannover Wistar rats were performed as 
described.18 Therefore, BMSCs were cultured in noncoated 
cell culture flasks in Minimum Essential Medium Alpha 
(Gibco, Darmstadt, Germany) supplemented with 15% 
fetal calf serum (FCS) (PAA Laboratories GmbH, Cölbe, 
Germany) and 1% penicillin/streptomycin (pen/strep, Gibco). 
Propagated cell cultures were processed to genetic modifi-
cation or left nontransfected and maintained in Minimum 
Essential Medium Alpha supplemented with 10% FCS and 
1% pen/strep (BMSC culture medium).
The nonviral plasmids for genetic modification of 
BMSCs were derived from the pCAGGS-empty vector.19 The 
plasmids encoding for enhanced green fluorescent protein 
(EGFP, pCAGGS-EGFP-Flag) and FGF-218kDa (pCAGGS-
FGF-218kDa-Flag, NCBI GenBank accession NM_019305.2, 
533-994 bp) have been previously described.20,21 The 
pCAGGS-GDNF-Flag plasmid was constructed by poly-
merase chain reaction-based cloning of the rat GDNF cod-
ing sequence (NCBI GenBank accession NM_019139.1, 
50-682 bp) using primers introducing MfeI and XbaI clon-
ing sites and removing the stop codon. The in-frame cloned 
C-terminal 3× Flag tag of the pCAGGS-Flag vector backbone 
enabled convenient detection of all three proteins (EGFP-
Flag, FGF-218kDa-Flag, GDNF-Flag) with the same antibody 
(anti-Flag M2, F1804 Sigma-Aldrich, Seelze, Germany). 
Internal reference numbers for the plasmids are given in 
parentheses for pCAGGS-empty (R399, used for control 
transfections), pCAGGS-EGFP-FLAG (R412), pCAGGS-
FGF-218kDa-FLAG (R417), and pCAGGS-GDNF-FLAG 
(R415). For the purpose of cell transfection, plasmid deoxy-
ribonucleic acid (DNA) has been purified using the QIAfilter 
Plasmid Maxi Kit (Qiagen, Hilden, Germany).
For the nonviral transfection, 2.5×106 viable (trypan blue 
negative) BMSCs were suspended in 90 µL basic transfection 
solution (Human MSC Kit, LONZA, Cologne, Germany) and 
mixed with 5 µg of the selected plasmid DNA in AMAXA 
specific cuvettes using the program A-33 (AMAXA II device, 
LONZA). The reaction was stopped by adding 900 µL RPMI 
1640 medium (Gibco) supplemented with 10% FCS, and the 
cell suspension was then transferred into new 15 mL falcon 
tubes. After centrifugation (5 minutes, 235× g), cell pellets 
were prepared for seeding into 0.5% NVR-Gel (based on 
either N2 medium or on PC-12 differentiation medium, 
see Figure 1B and 1C). The transfection efficiency, as 
exemplarily determined for EGFP-Flag-BMSCs in immuno-
fluorescence microscopy, reached about 60% (Figure S1 in 
“Supplementary materials”). We assume the same transfec-
tion rate also for the other transfections performed.
Drop cultures of dissociated neonatal 
Drg (sensory neurite outgrowth assay)
Neonatal DRGs were harvested from P1–P3 Hannover Wistar 
or Sprague Dawley rat pups (breeding pairs obtained from 
Janvier, Le Gernest-Saint Isle, France). Briefly, after decapi-
tation, the skin on the back was removed and the vertebral 
canal was longitudinally opened from the neck to the tail. 
The spinal cord was taken off and the DRGs were collected 
from intervertebral foramina at both sides of the vertebral 
canal. DRGs were kept for up to 1 hour in Hank’s balanced 
salt solution (w/o Mg and Ca, PAA Laboratories GmbH) prior 
to enzymatic dissociation at 37°C for 20 minutes in Hank’s 
balanced salt solution added with 0.125% trypsin (Gibco) 
and 0.05% DNase (Roche, Mannheim, Germany). Then, an 
additional 0.0075% collagenase type IV (0.1%, PAA Labora-
tories) was added and the dissociation continued for another 
20 minutes. DRGs were then mechanically dissociated using 
a fire-polished glass pipette before dissociation was stopped 
by adding 2.5 mL N2 cell culture medium (Dulbecco’s 
Modified Eagle’s Medium [DMEM] F-12, 1% pen/strep, 
0.25% bovine serum albumin, 2 mM L-glutamine, 1 mM 
sodium pyruvate, 1× N2 supplement; all PAA Laboratories) 
supplemented with 3% fetal bovine serum. Cells were then 
counted and placed as drop culture into the middle of 0.5% 
NVR-Gel (containing N2 medium) (Figure 1B).
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Neuronal differentiation assay  
with Pc-12 cells
During propagation of the PC-12 cell line from rat phae-
ochromocytoma cells of sympathoadrenal origin, a specific 
proliferation medium was used: DMEM high glucose + 10% 
horse serum + 5% FCS + 4 µM L-glutamine + 1 µM sodium 
pyruvate + 100 U/mL pen/strep.22 To analyze the neurite 
inductive potential of np-NTFs, np-NGF or np-FGF-218kDa 
was mixed into 0.5% NVR-Gel containing PC-12 cell differ-
entation medium: DMEM high glucose + 1% horse serum + 
1% FCS + 4 µM L-glutamine + 1 µM sodium pyruvate + 
100 U/mL pen/strep. To analyze the neurite inductive 
potential of nontransfected (nT-BMSCs) and FGF-218kDa-
overexpressing BMSCs (FGF-218kDa-BMSCs), the respective 
cells were seeded into 0.5% NVR-Gel containing PC-12 cell 
differentiation medium (Figure 1C). In order to enable spe-
cific monitoring of neuronal differentiation of PC-12 cells, 
the latter were nonvirally transfected to express EGFP. 
Therefore, pCAGGS-EGFP-FLAG (R412) was introduced to 
the cells using the AMAXA nucleofection technique similar 
to the procedures described (Cell Line Nucleofection Kit, 
program U-29, LONZA). For the neurite outgrowth assay, 
EGFP-PC-12 cells were mixed with np-NTFs or nT-BMSCs 
or FGF-218kDa-BMSCs. After 5 days of cultivation, the lengths 
of neuritic processes of EGFP-PC-12 cells were analyzed 
with fluorescence microscopy (Olympus IX 70 microscope, 
Olympus, Hamburg, Germany).
sodium dodecyl sulfate gel electrophoresis 
and Western blot analyses
Overexpression of selected NTFs by nonvirally transfected 
BMSCs was controlled using Western blot analyses of 
cell lysates. Therefore, nT-BMSCs, FGF-218kDa-BMSCs, 
and GDNF-BMSCs, as well as empty vector-transfected 
BMSCs (empty-BMSCs), were cultured with BMSC culture 
medium as listed in Figure 1C (passage 3, 4, and 5). After 
24 hours, proteins were extracted from sister culture cells 
and samples prepared for Western blotting. Additionally, 
cell culture supernatants (300 µL) were collected 24 hours, 
72 hours, and 120 hours after seeding of nT-BMSCs or after 
genetic modification (empty-BMSCs, FGF-218kDa-BMSCs, 
or GDNF-BMSCs) and concentrated using the speedvac 
system Con 1000 (LTF Labortechnik, Wasserburg, Ger-
many). A calculated protein concentration of 50 µg was 
prepared in Laemmli buffer following sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (15% gels). The 
separated proteins were electrophoretically transferred to a 
nitrocellulose membrane (Amersham Bioscience, Freiburg, 
Germany) as described.20 Immunodetection of FGF-218kDa 
or GDNF was performed in the Enhanced Chemilumines-
cence Imager System system (ECL, Intas, Science Imaging, 
Göttingen, Germany) using monoclonal anti-FGF-2 antibody 
(1:1,000; MerckMillipore, Darmstadt, Germany) or poly-
clonal anti-GDNF antibody (1:100; Santa Cruz, Heidelberg, 
Germany) followed by incubation with the respective anti-
mouse immunoglobulin G (IgG) or antirabbit IgG horse-
radish peroxidase-coupled secondary antibodies (1:4,000; 
both Amersham Bioscience Europe, Freiburg, Germany). 
Protein signals were detected in a horseradish peroxidase 
chemiluminescent reaction (Immobilon, Merck-Millipore, 
Schwalbach, Germany).
Immunocytochemistry
Transfection efficiency for nonviral genetic modification of 
BMSCs was determined using EGFP-Flag BMSCs. Cells 
were fixed for 30 minutes in 4% paraformaldehyde (PFA, 
Sigma-Aldrich). Prior to immunostaining, fixation was 
stopped by washing with phosphate-buffered saline.
Adult DRG explant cultures were also fixed for 
15 minutes in 4% PFA, while neonatal DRG drop cultures 
and PC-12 cell cultures in 0.5% NVR-Gel were fixed for 
30 minutes in 6% PFA.
Primary antibodies used were anti-βIII-tubulin (mono-
clonal mouse, 1:400, Sigma-Aldrich), anti-S100 antibody 
(polyclonal goat, 1:1,000, Dako, Glostrup, Denmark), and 
anti-Flag antibody (1:1,000, Sigma-Aldrich). Secondary anti-
bodies used were antimouse IgG Alexa-Fluor-488 conjugated 
(for adult DRG explants and BMSC assays, 1:500–1:2,000, 
Molecular Probes, Eugene, OR, USA) or antimouse IgG 
Alexa-Fluor-555 conjugated (for neonatal DRG drop cultures 
and EGFP-Flag-BMSCs, 1:500, Invitrogen) and rabbit anti-
goat IgG Alexa-Fluor-488 (1:500; Invitrogen). All primary 
antibodies were incubated overnight at 4°C and secondary 
antibodies for 1 hour at room temperature.
In addition, to identify BMSCs, the actin filaments were 
stained for 30 minutes with phalloidin-tritc fluorescence stain 
(1:500; Sigma-Aldrich).
All samples were stained with the nuclear marker 
4′,6-diamidino-2-phenylindole (1:1,000, 10 minutes, room 
temperature; Sigma-Aldrich).
Quantification of sensory neurite 
outgrowth
Adult DRG explants were scanned horizontally and images 
were merged in order to obtain three-dimensional pictures. 
The samples were observed with an LSM 510 confocal laser 
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microscopy system (Zeiss, Jena, Thuringia, Germany), which 
incorporates two lasers (argon and HeNe) and is equipped 
with an inverted Axiovert 100 M microscope. All images 
captured were digitally adjusted for optimal resolution.
During photomicrography, entire neonatal DRG drop 
cultures were taken in six or more overlapping image sec-
tions using the 4× objective of an inverted fluorescence 
microscope (Olympus IX 70, Olympus, Hamburg, Germany). 
The image sections were then automatically combined using 
Adobe Photoshop software to obtain a new aligned picture 
of the entire neuritic network.
Images of both adult DRG explants and neonatal DRG 
drop cultures were processed using image analysis software 
(ImageJ, National Institutes of Health, Bethesda, MD, USA) 
to evaluate the number of extending neurites in certain dis-
tances from the center of the cultures. For each sample, the 
perimeter of the DRG explant or the DRG drop was manually 
drawn (Polygon selection tool) and automatically enlarged 
(Edit–Selection–Enlarge tool) to create concentric curves at a 
fixed distance (50–200 µm for adult DRG and 500–1,100 µm 
for neonatal DRG) between each other. The number of inter-
sections of neuritic processes with the different curves was 
then counted and represented as mean values. Additionally, 
the maximum neurite lengths originating from neonatal DRG 
drop cultures were analyzed for the ten longest neurites.
statistical analysis
Three and four biological replicates were performed for 
experiments with adult DRG explants and neonatal DRG drop 
cultures, respectively. Each culture condition was analyzed 
for five adult DRG explants or two to three neonatal DRG 
drop cultures in each biological replicate. PC-12 cell assays 
were carried out in three biological replicates with two sister 
cultures per condition in each replicate. Western blot analyses 
were performed in three biological replicates. Results are 
reported as a mean ± standard deviation. Intergroup com-
parisons were made using one-way or two-ways analysis of 
variance followed by Bonferroni posttest. A probability value 
lower than 0.05 was considered as statistically significant.
Results
Np-NTFs demonstrate a prolonged 
bioactivity in vitro in comparison 
with free NTFs
To evaluate whether the bioactivity of NTFs is improved by 
conjugation of the proteins to nanoparticles in comparison 
with free recombinant proteins, we cultured adult rat DRG 
explants over 3 days in the presence of fresh and  preincubated 
medium formulations prepared with 50 ng/mL of free NTFs 
or NTFs conjugated to iron oxide nanoparticles (np-NTFs) 
and determined the numbers of extending neurites at certain 
distances from the DRG explant. GDNF was selected as ref-
erence NTF because it has demonstrated high bioactivity on 
adult DRG explant cultures, although with levels below NGF 
treatment (see Figure S2A). This made GDNF a candidate 
NTF to also detect minimal changes in bioactivity over time. 
As is depicted in Figure 2, incubation of adult DRG explant 
cultures for 3 days with fresh free GDNF or np-GDNF induced 
significantly increased numeric neurite outgrowth (Figure 2A) 
and extension of neuritic processes (Figure 2B) in comparison 
with control conditions with fresh medium without GDNF 
supplementation. Representative photomicrographs are given 
in Figure 2C. Fresh free GDNF additionally demonstrated an 
increased bioactivity over that of fresh np-GDNF. While the 
neurite outgrowth was not significantly affected after 1-week 
preincubation of medium formulations (data not shown), pro-
longed bioactivity of np-GDNF compared with free GDNF 
was clearly detectable after a 2-week preincubation period. 
After this period, free GDNF no longer increased numeric 
neurite outgrowth when compared with control conditions, 
and we detected a significant reduction of bioactivity by 65% 
of the bioactivity of fresh free GDNF. In contrast, np-GDNF 
revealed its bioactivity also after a 2-week preincubation 
period, as demonstrated by the maintained neurite outgrowth 
inductive activity, which was then still significantly increased 
over control conditions (Figure 2A and B).
Additionally, we demonstrated that at a certain dosage, 
all np-NTFs tested (np-NGF, np-FGF-218kDa, and np-GDNF) 
significantly increased adult sensory neurite outgrowth over 
the values seen in control cultures (cultured in SFM medium 
alone). All np-NTFs further demonstrated a dose dependency 
of their neurite inductive effects. The respective data are 
presented as supplementary material, including Figure S2.
np-NTFs exert the same bioactivity 
as free recombinant proteins when 
incorporated into a regenerative 
hydrogel matrix
After we could demonstrate that np-NTFs exert a neurite 
inductive effect on adult DRG explants, we further compared 
effects of free NTFs and np-NTFs on neurite outgrowth 
from neonatal DRG preparations placed into the nerve 
regenerative matrix NVR-Gel. NVR-Gel is composed of 
high molecular weight hyaluronic acid and laminin and has 
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Notes: (A) Bar graph depicting the number of neuritic extensions from adult Drg explants (at distance 0 µm) treated with free gDNF or np-gDNF. Medium formulations 
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distinct distances from the center of the Drgs (x-axis) and their distance from the center of the Drg explants (y-axis). (C) representative photomicrographs of adult Drg 
explant cultures in sFM supplemented with 50 ng/ml of free gDNF or np-gDNF freshly prepared or after a period of in vitro preincubation of 2 weeks. Neurites marked 
with anti-βIII-tubulin in green, scale bars: 200 µm.
Abbreviations: NTFs, neurotrophic factors; Drg, dorsal root ganglion; gDNF, glia-derived neurotrophic factor; np, nanoparticle; sFM, serum-free medium; cTr, 
control.
been described as regenerative matrix for nervous system 
repair.17,23 The next experiment was performed in order to 
determine whether the suspension of np-NTFs in the regen-
erative NVR-Gel matrix still allows them to exert inductive 
effects on neurite outgrowth, as seen for their suspension 
in medium. Therefore, the in vitro neurite outgrowth assay 
was analyzed after placing dissociated neonatal DRG drop 
cultures into 0.5% NVR-Gel supplemented with np-NTFs. 
To further elucidate whether conjugation of NTFs to iron 
oxide nanoparticles has an impact on the bioactivity of the 
NTF proteins, we compared in this experiment the effects 
of np-NTFs with those of free recombinant NTF proteins. 
As is depicted in Figure 3, the supplementation of NVR-Gel 
with either free NTF or np-NTF resulted in significant effects 
on neurite outgrowth induction from neonatal DRG drop 
cultures (Figure 3A, C, and E). Both free NGF and np-NGF 
induced significantly higher numeric neurite outgrowth in 
distances up 700 µm from the center of the DRG drop culture 
than the other NTFs (Figure 3A and B). However, analysis 
of the ten longest neurites extending from each DRG drop 
culture did not reveal any significant difference among all 
treatments (Figure 3G). No statistically significant difference 
was detectable between the neurite outgrowth inductive 
effects of np-NTFs compared with free NTFs, suggesting 
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that when incorporated into a regenerative hydrogel matrix, 
np-NTFs are able to exert the same bioactivity as free NTFs. 
Interestingly, for FGF-218kDa, an even slightly increased neu-
rite inductive potential over short distances was visible for 
np-FGF-218kDa in comparison with free FGF-218kDa (Figure 3C 
and D). The opposite was seen when comparing np-GDNF 
with free GDNF (Figure 3E and F).
Because we could demonstrate that np-NGF exerts the 
most prominent neurite inductive effect in both adult DRG 
explant cultures and neonatal DRG drop cultures, we were 
interested in whether this effect could be further increased 
by a possible synergistic effect of the other np-NTFs. 
Therefore, all three np-NTFs (np-NGF + np-FGF-218kDa + 
np-GDNF) were mixed to an np-NTF pool. As is shown in 
the supplementary material, including Figures S3 and S4, 
we observed that neither np-NTF pool concentration was 
able to significantly induce neurite outgrowth over the value 
achieved with the treatment with np-NGF alone.
BMscs overexpressing NTFs induce less 
sensory neurite outgrowth than np-NTFs
BMSCs were nonvirally transfected to induce overexpression 
of NTFs. Successful genetic modification was monitored 
in Western blot analysis from cell lysates and cell culture 
 supernatants (Figure 4). Cell lysates of engineered BMSCs 
reveal strong expression of the respective FGF-218kDa-Flag 
or pro-GDNF-Flag (Figure 4A). Cell culture supernatants 
collected from cultures of GDNF-BMSCs contain increased 
levels of pro-GDNF with increasing culture time as well 
as mature GDNF protein after 72–120 hours of culture 
( Figure 4B). On the contrary, nT-BMSCs culture superna-
tants contain low levels of endogenous pro-GDNF, while 
culture supernatants of the empty-BMSCs demonstrate a 
decreased expression of pro-GDNF (Figure 4B). With regard 
to FGF-2, neither endogenous FGF-218kDa nor FGF-218kDa-Flag 
was detectable in cell culture supernatants of nT-BMSCs or 
genetically engineered BMSCs (data not shown).
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Genetically engineered BMSCs were suspended in 
NVR-Gel and analyzed with respect to their neurite induc-
tive effect on neonatal DRG drop cultures. As is depicted 
in Figure 5, all types of genetically engineered BMSCs, but 
especially nT-BMSCs, demonstrated nonsignificant increase 
in numeric neurite outgrowth from DRG drop cultures over 
the value achieved in pure NVR-Gel (control [CTR]), and no 
significant difference was detected between the different cell 
types analyzed (Figure 5A). The maximum neurite lengths 
were almost not affected by the presence of nT-BMSCs 
(Figure 5C) in comparison with control levels (CTR), while 
engineered BMSCs (FGF-218kDa-BMSCs and GDNF-BM-
SCs) demonstrated nonsignificant impairment of distance 
outgrowth, which was most prominent in the presence of 
GDNF-BMSCs (Figure 5B). When comparing numeric 
neurite outgrowth from DRG drop cultures in the presence 
of engineered BMSCs with the incubation with np-FGF-218kDa 
or np-GDNF, respectively, no significant differences were 
detectable ( Figure 6A). However, it is noteworthy that while 
nT-BMSCs had a very similar effect on maximum neurite 
lengths as np-NTFs, co-culture with engineered BMSCs, 
especially GDNF-BMSCs, significantly impaired distance 
outgrowth of neurites (Figure 6B).
Neurite formation by Pc-12 cells 
is supported to a higher extent in the 
presence of FgF-218kDa-BMscs than 
in the presence of np-FgF-218kDa
In order to directly compare the neurite inductive potential 
of np-NTFs and engineered NTF-BMSCs again in another 
cell system, we utilized the PC-12 cell neuronal differentia-
tion assay as a third in vitro model. PC-12 cells are highly 
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sensitive for treatment with NGF or FGF-218kDa. Therefore, 
free NGF, np-NGF, free FGF-218kDa, np-FGF-218kDa, or 
 FGF-218kDa-BMSCs were incorporated in NVR-Gel together 
with PC-12 cells. As is shown in Figure 7, 50 ng/mL of 
np-NGF demonstrated a slightly stronger neurite outgrowth 
inductive potential than 50 ng/mL free NGF (positive control 
condition) or free FGF-218kDa and np-FGF-218kDa (Figure 7A). 
Interestingly, the presence of nT-BMSCs significantly 
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impaired neurite outgrowth from PC-12 cells when compared 
with all other conditions, while FGF-218kDa-BMSCs (Figure 
7B) demonstrated a significantly increased effect on neuronal 
differentiation of PC-12 cells in comparison with free FGF-
218kDa or np-FGF-218kDa.
Discussion
In this study, we compared in vitro two different possible 
approaches to deliver NTFs within artificial grafts for periph-
eral nerve reconstruction. The first was the nanotechnology 
approach of conjugation of NTFs with iron oxide nanopar-
ticles, which was supposed to increase the stability of the 
conjugated NTFs, but also to ensure local and slow release of 
NTFs in the lumen of nerve conduits.5 The second approach 
we studied was stem cell engineering. Here, we induced NTF 
overexpression in BMSCs with nonviral genetic modifica-
tion. The genetically engineered BMSCs could potentially be 
transplanted within tissue-engineered nerve conduits, as has 
been successfully done before with genetically engineered 
Schwann cells.4
In order to compare the feasibility of optimized NTF 
delivery increasing the neurite outgrowth in vitro, we utilized 
adult DRG explant organotypic cultures as well as neonatal 
DRG drop cultures. The DRG neurite outgrowth model is 
widely used to assess the neurite outgrowth in a specific 
environment.24,25
Using adult DRG explant cultures, we demonstrate that 
the bioactivity of np-NTFs is comparable with that of free 
NTFs when incorporated into a regenerative hydrogel matrix. 
The latter is a good prerequisite for future in vivo application. 
From previous studies, we already have proof that NTFs con-
jugated to iron oxide nanoparticles demonstrate prolonged 
stability over free NTFs.14 Here, we clearly demonstrate that 
not only the stability of the proteins but also, most impor-
tantly, their bioactivity is stabilized by conjugation of NTFs 
to nanoparticles. Our study comparing the neurite inductive 
potential of fresh with preincubated medium formulations 
evidenced that only minimal reduction of bioactivity occurs 
for np-GDNF during a 2-week preincubation period, while 
free GDNF lost its neurite inductive activity in the same 
time span.
We could further demonstrate that np-NTFs are able to 
stimulate neuronal outgrowth in a dose-dependent manner 
and that np-NTFs have similar bioactivity as free NTFs when 
suspended in a regenerative hydrogel matrix. The latter sys-
tem mimics a way to apply np-NTFs with nerve conduits for 
peripheral nerve reconstruction surgery. As hydrogel matrix, 
we used NVR-Gel, which has been described before as a 
suitable matrix for neuronal cultures17 and which seemed 
to be appropriate as luminal filler for artificial nerve con-
duits. Using neonatal DRG drop cultures we demonstrate 
that np-NTFs are effective in inducing the numeric neurite 
outgrowth activity also when suspended in NVR-Gel. In 
NVR-Gel enriched with np-NTFs, the elongation of neurites, 
however, seems not to be stimulated. We suppose that the 
presence of the gel slowed down neurite elongation, but 
further analysis using long-term cultures is necessary to 
elucidate how neurite distance outgrowth is influenced by 
NVR-Gel.
With regard to potential in vivo application of np-NTFs, 
another finding from our study has to be considered. The 
dose dependency of np-NTF-induced sensory neurite 
outgrowth varied among the NTFs investigated. While 
50 ng/mL of np-NGF or np-GDNF induced maximal neu-
rite outgrowth among the concentrations chosen, the lower 
concentration of only 10 ng/mL np-FGF-218kDa showed a 
trend to be more efficient than higher concentrations (data 
presented as supplementary material). All np-NTFs inves-
tigated, however, demonstrated an induction of neurite 
outgrowth activity at the concentration of 50 ng/mL, which 
can be concluded as a useful concentration for future in 
vivo application. From the acquired in vitro data, it cannot 
be finally decided which np-NTFs would give maximum 
support of axonal regeneration in vivo. DRG neuron popula-
tions are heterogeneous with regard to the quality of sensory 
transmission, and different growth factors act selectively 
on different subpopulations of DRG neurons.26–29 Therefore, 
an emerging concept in the field of artificial nerve graft 
development is to use a combination of NTFs with the aim 
to obtain a widespread effect on all sensory, motor, and 
sympathetic neuronal subpopulations.30–32 It is, however, 
still under debate which NTF combination will result in 
the most successful support of PNR while simultaneously 
avoiding negative influences in the process.33 Therefore, we 
also investigated the effect of an np-NTF pool on the neurite 
outgrowth activity in adult DRG explant and neonatal DRG 
drop cultures. In our hands, an np-NTF pool of np-NGF, 
np-FGF-218kDa, and np-GDNF did not demonstrate higher 
efficiency in promoting neurite outgrowth than 50 ng/mL 
np-NGF alone. This indicates that there is no synergistic 
effect among these three selected NTFs. However, con-
sidering the limits of an in vitro approach, it is possible 
that in our culture systems, 50 ng/mL np-NGF treatment 
already induced the maximum neurite outgrowth with no 
possibility to demonstrate a synergy for the additionally 
added np-FGF-218kDa or np-GDNF.
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Evaluation of the second innovative approach of NTF 
delivery to nerve conduits and stem cell engineering showed 
that primary nT-BMSCs have a higher potency to induce 
sensory neurite outgrowth than engineered NTF-BMSCs. 
The basis for this may be the secretome of BMSCs that 
provides a variety of growth factors to the co-cultured 
 neurons.34 We assume that the secretome has, to some 
extent, been negatively influenced by the genetic modifica-
tion during BMSC engineering. Further analysis is needed 
to elucidate this in more detail prior to potential in vivo 
application, but, although only seen in one out of three 
independent analyses, the Western blot analysis shown in 
Figure 4B already indicates that the GDNF expression might 
be altered between nT-BMSCs and genetically engineered 
empty-BMSCs.
When comparing the two innovative approaches of nano-
technology and stem cell engineering with regard to sensory 
neurite outgrowth, however, np-NTFs have demonstrated a 
slightly increased bioactivity over NTF-BMSCs. Addition-
ally, using a different neuronal differentiation model,22,35 the 
PC-12 cell neurite outgrowth induction assay, NTF-BMSCs 
demonstrated an increased bioactivity over np-NTFs. We 
therefore assume that the secretome together with the overex-
pressed FGF-218kDa was, in this setting, specifically supportive 
for PC-12 cell sympathetic neurite outgrowth.
One last point has to be considered when thinking of 
future in vivo application of nanotechnological NTF delivery 
to peripheral nerve guidance conduits. The conduits will be 
sutured between the transected nerve ends and, especially 
the distal nerve end, will undergo Wallerian degeneration. 
As this process will provide Schwann cell ingrowth into the 
nerve conduits, we were also interested in whether Schwann 
cell migration is modified in our in vitro models. The data 
are not shown because we have no hints that Schwann cell 
migration is modified by adding np-NTFs or BMSCs to the 
system. Whether synergistic effects would develop for np-
NTFs delivered within the conduits and those additionally 
liberated during Wallerian degeneration of the distal nerve 
end, is only accessible in vivo and must be the subject of 
future studies.
Conclusion
Both approaches demonstrated their potential to induce neu-
rite outgrowth in different neuronal models. They may be 
chosen specifically in the context of peripheral nerve tissue 
engineering. However, the variability of the BMSC secretome 
upon genetic engineering of the cells needs to be studied in 
more detail prior to their in vivo application. Our comparative 
in vitro study provides evidence that np-NTFs have long-
term bioactivity and reliably support neurite outgrowth in 
vitro also after periods when free NTFs have already lost 
their bioactivity. With regard to their therapeutical use, iron 
oxide nanoparticles are considered to be nontoxic and are 
already in use for various biomedical applications, such as 
diagnostics, cell labeling, magnetic resonance imaging, and 
X-ray contrast agents, and for hyperthermia.5 Therefore, np-
NTFs are good candidates for the in vivo evaluation of their 
PNR-promoting potential in future studies.
Acknowledgments
This project has received funding from the European Union’s 
Seventh Programme for Research, Technological Devel-
opment and Demonstration under Grant Agreement No 
278612. For excellent technical assistance, we thank Maike 
Wesemann from the Institute of Neuroanatomy at Hannover 
Medical School. For support in bone marrow-derived mesen-
chymal stem cell cultures, we thank Antonio J Salgado from 
the University of Minho, Braga, Portugal.
Disclosure
The authors report no conflicts of interest in this work.
References
 1. Tos P, Ronchi G, Geuna S, Battiston B. Future perspectives in nerve 
repair and regeneration. Int Rev Neurobiol. 2013;109:165–192.
 2. Deumens R, Bozkurt A, Meek MF, et al. Repairing injured peripheral 
nerves: bridging the gap. Prog Neurobiol. 2010;92(3):245–276.
 3. Geuna S, Gnavi S, Perroteau I, Tos P, Battiston B. Tissue engineering 
and peripheral nerve reconstruction: an overview. Int Rev Neurobiol. 
2013;108:35–57.
 4. Haastert K, Grothe C. Gene therapy in peripheral nerve reconstruction 
approaches. Curr Gene Ther. 2007;7(3):221–228.
 5. Ziv-Polat O, Skaat H, Shahar A, Margel S. Novel magnetic fibrin hydro-
gel scaffolds containing thrombin and growth factors conjugated iron 
oxide nanoparticles for tissue engineering. Int J Nanomedicine. 2012; 
7:1259–1274.
 6. Madduri S, Gander B. Schwann cell delivery of neurotrophic factors 
for peripheral nerve regeneration. J Peripher Nerv Syst. 2010;15(2): 
93–103.
 7. Haastert K, Lipokatic E, Fischer M, Timmer M, Grothe C. Differ-
entially promoted peripheral nerve regeneration by grafted Schwann 
cells over-expressing different FGF-2 isoforms. Neurobiol Dis. 2006; 
21(1):138–153.
 8. Haastert K, Ying Z, Grothe C, Gomez-Pinilla F. The effects of FGF-2 
gene therapy combined with voluntary exercise on axonal regeneration 
across peripheral nerve gaps. Neurosci Lett. 2008;443(3):179–183.
 9. Oliveira JT, Mostacada K, de Lima S, Martinez AM. Bone marrow 
mesenchymal stem cell transplantation for improving nerve regenera-
tion. Int Rev Neurobiol. 2013;108:59–77.
 10. Johnson EO, Charchanti A, Soucacos PN. Nerve repair: experimental 
and clinical evaluation of neurotrophic factors in peripheral nerve 
regeneration. Injury. 2008;39 Suppl 3:S37–S42.
 11. Catrina S, Gander B, Madduri S. Nerve conduit scaffolds for dis-
crete delivery of two neurotrophic factors. Eur J Pharm Biopharm. 
2013;85(1):139–142.
International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5302
Morano et al
 12. Klimaschewski L, Hausott B, Angelov DN. The pros and cons of 
growth factors and cytokines in peripheral axon regeneration. Int Rev 
Neurobiol. 2013;108:137–171.
 13. Molday RS, MacKenzie D. Immunospecific ferromagnetic iron-dextran 
reagents for the labeling and magnetic separation of cells. J Immunol 
Methods. 1982;52(3):353–367.
 14. Ziv-Polat O, Shahar A, Levy I, et al. The role of neurotrophic factors 
conjugated to iron oxide nanoparticles in peripheral nerve regeneration: 
in vitro studies. Biomed Res Int. 2014;2014:1–10.
 15. Shahar A, Ziv-Polat O, Margel S, Freier T. Developing a customized 
tissue-engineered implant for peripheral nerve reconstruction: role of 
nanoparticles. In: Bhoop BS, ed. Medical Nanobiotechnology. Vol 5. 
Houston, TX: Studium Press LLC; 2014.
 16. Fueshko S, Wray S. LHRH cells migrate on peripherin fibers in 
embryonic olfactory explant cultures: an in vitro model for neurophilic 
neuronal migration. Dev Biol. 1994;166(1):331–348.
 17. Shahar A, Nevo Z, Rochkind S, inventors. Cross-linked hyaluronic 
acid-laminin gels and use thereof in cell culture and medical implants. 
United States patent US 00243732001. November 13, 2001.
 18. Wrobel S, Serra SC, Ribeiro-Samy S, et al. In vitro evaluation of cell-
seeded chitosan films for peripheral nerve tissue engineering. Tissue 
Eng Part A. 2014;20(17–18):2339–2349.
 19. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-
expression transfectants with a novel eukaryotic vector. Gene. 1991; 
108(2):193–199.
 20. Ratzka A, Kalve I, Ozer M, et al. The colayer method as an efficient 
way to genetically modify mesencephalic progenitor cells transplanted 
into 6-OHDA rat model of Parkinson’s disease. Cell Transplant. 
2012;21(4):749–762.
 21. Ratzka A, Baron O, Grothe C. FGF-2 deficiency does not influence FGF 
ligand and receptor expression during development of the nigrostriatal 
system. PLoS One. 2011;6(8):e23564.
 22. van Bergeijk J, Haastert K, Grothe C, Claus P. Valproic acid promotes 
neurite outgrowth in PC12 cells independent from regulation of the 
survival of motoneuron protein. Chem Biol Drug Des. 2006;67(3): 
244–247.
 23. Rochkind S, Shahar A, Fliss D, et al. Development of a tissue-engineered 
composite implant for treating traumatic paraplegia in rats. Eur Spine J. 
2006;15(2):234–245.
 24. Melli G, Hoke A. Dorsal root ganglia sensory neuronal cultures: a 
tool for drug discovery for peripheral neuropathies. Expert Opin Drug 
Discov. 2009;4(10):1035–1045.
 25. Bilsland J, Rigby M, Young L, Harper S. A rapid method for semi-
quantitative analysis of neurite outgrowth from chick DRG explants 
using image analysis. J Neurosci Methods. 1999;92(1–2):75–85.
 26. Benedetti M, Levi A, Chao MV. Differential expression of nerve growth 
factor receptors leads to altered binding affinity and neurotrophin 
responsiveness. Proc Natl Acad Sci U S A. 1993;90(16):7859–7863.
 27. Bennett DL, Michael GJ, Ramachandran N, et al. A distinct  subgroup 
of small DRG cells express GDNF receptor components and GDNF 
is protective for these neurons after nerve injury. J Neurosci. 1998; 
18(8):3059–3072.
 28. Wright DE, Snider WD. Neurotrophin receptor mRNA expression 
defines distinct populations of neurons in rat dorsal root ganglia. 
J Comp Neurol. 1995;351(3):329–338.
 29. Xiao J, Wong AW, Willingham MM, et al. BDNF exerts contrasting 
effects on peripheral myelination of NGF-dependent and BDNF-
dependent DRG neurons. J Neurosci. 2009;29(13):4016–4022.
 30. Sharma HS. Neurotrophic factors in combination: a possible new 
therapeutic strategy to influence pathophysiology of spinal cord injury 
and repair mechanisms. Curr Pharm Des. 2007;13(18):1841–1874.
 31. Madduri S, di Summa P, Papaloizos M, Kalbermatten D, Gander B. Effect 
of controlled co-delivery of synergistic neurotrophic factors on early 
nerve regeneration in rats. Biomaterials. 2010;31(32):8402–8409.
 32. Blesch A, Fischer I, Tuszynski MH. Gene therapy, neurotrophic factors 
and spinal cord regeneration. Handb Clin Neurol. 2012;109:563–574.
 33. Madduri S, Gander B. Growth factor delivery systems and repair 
strategies for damaged peripheral nerves. J Control Release. 2012; 
161(2):274–282.
 34. Ribeiro CA, Salgado AJ, Fraga JS, Silva NA, Reis RL, Sousa N. 
The secretome of bone marrow mesenchymal stem cells-conditioned 
media varies with time and drives a distinct effect on mature neu-
rons and glial cells (primary cultures). J Tissue Eng Regen Med. 
2011;5(8):668–672.
 35. van Bergeijk J, Rydel-Konecke K, Grothe C, Claus P. The spinal mus-
cular atrophy gene product regulates neurite outgrowth: importance of 
the C terminus. Faseb J. 2007;21(7):1492–1502.
International Journal of Nanomedicine 2014:9 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
5303
Neurite induction by nanotechnology versus stem cell engineering
Supplementary materials
Neurotrophic factors conjugated 
to iron oxide nanoparticles induce a 
dose-dependent neurite outgrowth from 
adult dorsal root ganglion explants
Adult rat dorsal root ganglion (DRG) explants were cul-
tured over 3 days in the presence of increasing amounts 
of neurotrophic factors conjugated to iron oxide nanopar-
ticles (np-NTFs), and the numbers of extending neurites 
measured at certain distances from the DRG explant. As 
is depicted in Figure S2, at a certain dosage, all np-NTFs 
tested significantly increased adult sensory neurite out-
growth over the values seen in control cultures (cultured 
in serum-free medium alone). All np-NTFs demonstrated 
a dose dependency of their neurite inductive effects. The 
strongest effect on numeric neurite outgrowth (Figure 
S2A) was seen for the treatment with 50 ng/mL of either 
np-NGF or np-glia-derived neurotrophic factor (GDNF). 
Lower or higher medium concentrations of both np-NGF 
and np-GDNF showed reduced effects with significantly 
lower neurite numbers for the reduced concentration of 10 
ng/mL of np-NGF and the elevated concentration of 100 ng/
mL of np-GDNF, respectively. Only minimal differences 
in the numeric neurite outgrowth were detectable for the 
treatment with different concentrations of np-fibroblast 
growth factor (FGF)-218kDa. While a significant increase of 
neurite numbers over control levels was already detectable 
for the lowest concentration of 10 ng/mL np-FGF-218kDa, 
the elevated concentrations no longer induced significant 
effects on neurite outgrowth. As is depicted in Figure S2B, 
the strongest effect on neurite elongation was detected 
under treatment with np-NGF by which, again, 50 ng/mL 
induced the maximum neurite lengths in the highest number 
of neurites. But treatment with 50 ng/mL np-FGF-218kDa also 
induced outgrowth of longer neurites, up to a distance of 450 
µm from the center of the DRG, than all other treatments 
except the one with np-NGF. Under control conditions, 
outgrowing neurites reached a distance of only 300 µm 
from the DRG center.
combination of three different 
neurotrophic factors conjugated  
to np-NTFs fails to further increase the 
neurite inductive effect of np-NgF alone
Because a concentration of 50 ng/mL np-NGF had dem-
onstrated the most prominent neurite inductive effect, 
we were interested in whether this effect could be further 
increased by a possible synergistic effect of the other np-
NTFs. Therefore, all three np-NTFs (np-NGF + np-FGF-
218kDa + np-GDNF) were mixed to an np-NTF pool of two 
different concentrations: 30 ng/mL (each np-NTF) and 
50 ng/mL (each np-NTF). As is demonstrated in Figure S3, 
we observed that neither np-NTF pool concentration was 
able to significantly induce neurite outgrowth over the value 
achieved with the treatment with 50 ng/mL np-NGF alone. 
The numeric neurite outgrowth from adult DRG explants 
was significantly increased over control levels in both np-
NTF pool treatments, which were not significantly different 
from each other (Figure S3A). Significantly longer neurites 
than under control conditions were induced by both np-NTF 
pool treatments as well (Figure S3B). However, treatment 
with 50 ng/mL np-NGF alone demonstrated a tendency to 
induce an even more increased number of long neurites (up 
to 500 µm from the center of the DRGs).
Additionally to testing the neurite inductive effects of 
np-NTFs, we again analyzed the bioactivity of an np-NTF 
pool (50 ng/mL of each np-NGF, np-FGF 218kDa, and np-
GDNF) suspended in NVR-Gel. Similar to the results after 
incubation of adult DRG explant cultures with an np-NTF 
pool, we observed no synergistic effect. As is shown in 
Figure S4, the neurite inductive potential of the np-NTFs 
pool was similar to that of 50 ng/mL np-NGF alone.
A BnT-BMSCs EGFP-Flag-BMSCs Anti-Flag
DAPI
F-actin
DAPI
100 µm 100 µm
Figure S1 Nontransfected and egFP-Flag-BMscs in culture.
Notes: (A) nT-BMSCs stained for F-actin filaments (red), demonstrating their regular fibroblast-like shape. (B) anti-Flag (red) stained BMscs after nonviral transfection with 
egFP-Flag. Nuclear staining with 4′,6-diamidino-2-phenylindole (blue).
Abbreviations: EGFP, enhanced green fluorescent protein; BMSCs, bone marrow-derived mesenchymal stromal cells; nT, nontransfected.
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Figure S2 Neurotrophic factors conjugated to iron oxide nanoparticles stimulate neurite outgrowth from adult Drg explants in a dose-dependent manner.
Notes: (A) Bar graph representing the number of neuritic extensions from adult Drg explants (at distance 0 µm) treated with different amounts of np-NTFs. statistical 
analysis revealed the strongest effect on neurite outgrowth when explants were treated with 50 ng/ml of either np-NgF or np-gDNF. Treatment with 10 ng/ml np-FgF-
218kDa already evoked a significant increase of neurite outgrowth when compared with untreated controls. Bars represent mean values ± standard deviations (**P#0.01, 
***P#0.001). (B) line graph representing the number of intersections of the neuritic processes with circles drawn in distinct distances from the center of the Drgs (x-axis) 
and their distance from the center of the Drg explants (y-axis).
Abbreviations: Drg, dorsal root ganglion; np, nanoparticle; NTFs, neurotrophic factors; NgF, nerve growth factor; gDNF, glia-derived neurotrophic factor; FgF, 
fibroblast growth factor; CTR, control.
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Figure S3 combined administration of the three np-NTFs fails to increase the number of neurites extending from adult Drg explants.
Notes: (A) Bar graph representing the number of neuritic extensions of adult Drg explants (at distance 0 µm) treated with np-NgF (50 ng/ml) or with an np-NTF pool 
(np-NgF + np-FgF-218kDa + np-gDNF) in the concentration of 30 ng/ml (each np-NTF) or 50 ng/ml (each np-NTF), respectively. Bars represent mean values ± standard 
deviations (*P#0.05, ***P#0.001). (B) line graph representing the number of intersections of the neuritic processes with circles drawn in distinct distances from the center 
of the DRGs (x-axis) and their distance from the center of the DRG explants (y-axis). No significant increase over the neurite outgrowth inductive effect seen with treatment 
with 50 ng/ml np-NgF alone could be achieved by treatment with any np-NTF pool. With regard to neurite lengths, the strongest effect has rather been detected for the 
single treatment with np-NgF.
Abbreviations: np, nanoparticle; NTFs, neurotrophic factors; DRG, dorsal root ganglion; NGF, nerve growth factor; FGF, fibroblast growth factor; GDNF, glia-derived 
neurotrophic factor; cTr, control.
International Journal of Nanomedicine
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/international-journal-of-nanomedicine-journal
The International Journal of Nanomedicine is an international, peer-
reviewed journal focusing on the application of nanotechnology 
in diagnostics, therapeutics, and drug delivery systems throughout 
the biomedical field. This journal is indexed on PubMed Central, 
 MedLine, CAS, SciSearch®, Current Contents®/Clinical Medicine, 
Journal Citation Reports/Science Edition, EMBase, Scopus and the 
Elsevier Bibliographic databases. The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/
testimonials.php to read real quotes from published authors.
International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
5306
Morano et al
A
N
um
be
r o
f i
nt
er
se
ct
io
ns
N
eu
rit
e 
le
ng
th
 (µ
m
)
Distance from the cell bodies (µm)
400
1,500
1,250
1,000
750
500
250
0
***
***
**
CTR
np-NGF
np-NTPs-pool*
300
200
100
40
30
20
10
0
500 700 900 1,100
CTR np-NGF np-NTPs-
pool
B
Figure S4 No synergistic effect is induced by supplementing NVr-gel with a pool of np-NTFs.
Notes: (A) Bar graphs depicting the number of neurite intersections (y-axis) with circles drawn at distinct distances (x-axis) from the neonatal Drg drop culture under 
control conditions or treatment with 50 ng/mL np-NGF or the 50 ng/mL np-NTF pool. No statistically significant difference between the neurite inductive potential of np-
NgF and np-NTF pool was detectable (*P#0.05, **P#0.01, ***P#0.001). (B) Bar graph illustrating the mean length ± standard deviation of the ten longest neurites extending 
from each of the DRG drop cultures. No significant difference was detectable between both treatments.
Abbreviations: np, nanoparticle; NTFs, neurotrophic factors; Drg, dorsal root ganglion; NgF, nerve growth factor; cTr, control.
